Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort-Reference-Cited by-同舟云学术

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

Published:2018-09-01 Issue:9 Volume:75 Page:1062
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

de Wilde Arno¹,van der Flier Wiesje M.¹²,Pelkmans Wiesje¹,Bouwman Femke¹,Verwer Jurre³,Groot Colin⁴,van Buchem Marieke M.¹,Zwan Marissa¹,Ossenkoppele Rik¹⁴,Yaqub Maqsood⁴,Kunneman Marleen⁵,Smets Ellen M. A.⁵,Barkhof Frederik⁴⁶,Lammertsma Adriaan A.⁴,Stephens Andrew⁷,van Lier Erik⁸,Biessels Geert Jan³,van Berckel Bart N.¹⁴,Scheltens Philip¹

Affiliation:

1. Department of Neurology & Alzheimer Center, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands

2. Department of Epidemiology & Biostatistics, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands

3. Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands

4. Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands

5. Department of Medical Psychology, Amsterdam Neuroscience, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

6. Institutes of Neurology and Healthcare Engineering, University College London, London, England

7. Piramal Imaging GmbH, Berlin, Germany

8. BV Cyclotron, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Reference56 articles.

1. Alzheimer’s disease: the amyloid cascade hypothesis.;Hardy;Science,1992

2. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics.;Hardy;Science,2002

3. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers.;Jack;Lancet Neurol,2013

4. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.;Klunk;Ann Neurol,2004

5. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.;McKhann;Alzheimers Dement,2011

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for measuring concentrations and forms of amyloid-β peptides;Biosensors and Bioelectronics;2024-09

2. Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-30

3. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study;Molecular Psychiatry;2024-08-23

4. Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia;Neurology;2024-08-13

5. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice;Alzheimer's & Dementia;2024-08-03